FDA Investigator Kristina L Conroy

Kristina L Conroy has conducted inspections on 23 sites in 2 countries as of 13 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
23
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Canada
FDA Investigators that have inspected at least one site in common with Kristina L Conroy:
Adetutu M Gidado, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amber D Brodas, Amy Chen, Amy L Singer, Amy N Chen, Anastasia I Onuorah, Anastasia M Shields, Anita R Michael, Antonina Aydanian, Audrey Thereset Uy, Barbara A Gullick, Barbara Jwilimczyk Macri, Bijoy Panicker, Brooke K Higgins, Brooke K Seeman, Byungja E Marciante, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charles Jewell, Cheryl A Clausen, Chiang Syin, PhD, Christina K Theodorou, Christina N Maurino, Christine M Cerenzio, Cody D Rickman, Craig D Zagata, Daniel J Grabicki, David A Oluwo, Dawn L Wydner, Debra J Bennett, Debra L Pagano, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Diane L Raccasi, Donald L Lech, Douglas A Campbell, Dr. Dominick Roselle, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Emest F Bizjak, Emily A Walters, Eric L Dong, BS, Frank W Perrella, Frederick F Razzaghi, Freyja V Lynn, Gayle S Lawson, George Pyramides, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Hector Jcolon Torres, Helen B Ricalde, Helen Verdel, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James C Maclaughlin, James M Mason, James M Simpson, James P Mcevoy, James R Birkenstamm, Jay T Wong, Jean Blackston Hill, Jean M Kelahan, Jeen S Min, Jeffery B Medwid, PhD, Jennifer L Bridgewater, Jogy George, Jonah S Ufferfilge, Jonathan W Chapman, Jose Acruz Gonzalez, Jose M Cayuela, Joseph L Despins, PhD, Joseph W Matthews, Joy Rkozlowski Klena, Juanita P Versace, Julianne C Mccullough, Junho Pak, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Karen L Kosar, Kathleen D Culver, Kathleen M Jordan, Kenneth H Williams, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Ko U Min, Lata C Mathew, PhD, Lawrence Harmon, Jr, Leanna M Slarsky, Liatte Kreuger, PharmD, Linda M Hoover, Lisa B Orr, Lori Peters, Lori S Lawless, Luella J Rossi, Luis A Dasta, Marc S Neubauer, Marcellinus D Dordunoo, Marcus A Ray, Marea K Harmon, Margaret M Doherty, Margaret M Sands, Maria Estrella, Maria Joselopez Barragan, PhD, Marjorie A Shapiro, PhD, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew A Spataro, Matthew B Casale, Matthew M Henciak, Matthew R Noonan, Melissa J Garcia, Michael A Taylor, Michael D Omeara, Michael Gurbarg, Michael R Klapal, Michael Shanks, MS, Mihaly S Ligmond, Milan S Blake, Monika Borkowska, Nadeem I Chaudhry, Nancy F Scheraga, Nancy M Espinal, Nancy N Bellamy, Nancy T Waites, Nebil A Oumer, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Omotunde O Osunsanmi, Patsy J Domingo, Paul L Bellamy, Paul Mouris, Paula A Trost, Paula J Bretz, Perry T Nichols, Prabhu P Raju, Rachael O Oyewole, Rachel C Harrington, Rahi D Patel, Rebecca Rodriguez, Regina T Brown, Richard J Muzeni, Richard W Thornton, Robert C Coleman, Robert C Steyert, Robert H Wittorf, Robert J Martin, Robert Jennings, Ruben C Quintana, Russell J Glapion, Saleem A Akhtar, Samina S Khan, Sangeeta M Khurana, PhD, Sarah B Tanksley, Sarah Forney, Sayyem H Akbar, Scott E Norris, Sean R Marcsisin, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Sinai I Davis, Suchan Kim, Susan F Laska, MS, Susan M Jackson, Tammy L Chavis, Tania E Garcia, Tania E Vizcaino, Temar Q Williams, Thomas E Friel, Thomas R Withers, Tina S Roecklein, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Viviana Matta, Vivin George, Vlada Matusovsky, Walter L Fava, Wanda Y Honeyblue, Wayne E Seifert, William J Leonard, Yaharn Su, Yoriann M Cabrera Bartolomei, Yvesna C Blaise, Yvins Dezan, Yvonne C Mcknight, Yvonne C Wood, Zakaria I Ganiyu, Zhongren Wu

Kristina L Conroy's Documents

Publish Date Document Type Title
May, 2023 FDA 483 AptaPharma Inc. - Form 483, 2023-05-15
April, 2022 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2022-04-13
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
August, 2021 FDA 483 Teligent, Inc. - Form 483, 2021-08-31
November, 2022 FDA 483 CareFirst Specialty Pharmacy LLC - Form 483, 2022-11-30
March, 2022 FDA 483 Wedgewood Village Pharmacy, LLC - Form 483, 2022-03-24
October, 2022 FDA 483 Response Sure-Biochem Laboratories, LLC - Form 483R, 2022-10-27
December, 2021 FDA 483 Response DuPont Nutrition USA, Inc - Form 483R, 2022-01-12
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
December, 2021 EIR DuPont Nutrition USA, Inc - EIR, 2021-12-15
October, 2022 FDA 483 Sure-Biochem Laboratories, LLC - Form 483, 2022-10-07
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
June, 2021 FDA 483 Douglas Pharma US Inc. - Form 483, 2021-06-15
December, 2022 EIR Quotient Sciences - Philadelphia, LLC - EIR, 2023-02-03
December, 2021 FDA 483 DuPont Nutrition USA, Inc - Form 483, 2021-12-15
August, 2022 FDA 483 Eurofins SF Analytical Laboratories, Inc - Form 483, 2022-08-09
November, 2023 FDA 483 Q-Pharm Inc. - Form 483, 2023-11-15
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
October, 2021 FDA 483 Afton Scientific, LLC - Form 483, 2021-10-22
December, 2022 FDA 483 Quotient Sciences - Philadelphia, LLC - Form 483, 2022-12-22
February, 2023 FDA 483 Veranova, L.P. - Form 483, 2023-02-15
September, 2023 FDA 483 EMSL Analytical, Inc. - Form 483, 2023-09-29
November, 2023 FDA 483 Contract Pharmaceuticals Limited Canada - Form 483, 2023-11-03
April, 2023 FDA 483 Nelson Laboratories Fairfield Inc. - Form 483, 2023-04-05
May, 2021 EIR Johnson & Johnson Consumer Inc. - EIR, 2021-05-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more